跳至主要内容
临床试验/CTRI/2025/06/089594
CTRI/2025/06/089594尚未招募2 期

Randomized comparative clinical study to evaluate efficacy of virechan karma using Kashmaryadi kashay and Ardhamatrik niruh basti in vaatrakta with special reference to gout.

Dr Shubhada Santosh Kulkarni1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年9月7日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
decrease in serum uric acid level

研究概览

简要总结

Vatarakta is a great medical problem throughout the world. It is a great enemy in the society, because it distresses the human life. In Ayurvedic context, various treatment modalities have been suggested to get rid of this disease. In Vatarakta, both Vata and Rakta get aggravated and vitiated by their hetus and ultimately vayu gets obstructed by vitiated Rakta.

The classical texts lay down ample importance to the functions and characteristics of vata. At the same time, rakta being the foremost body tissue also plays an important role in sustaining the healthy life style of a person. Vatarakta is a disease where both VataandRakta are afflicted by distinct etiological factors. The disease characterized by the abnormality of raktadhatu due to morbidity of vatadosha is called as Vatarakta. “Vatadushitamraktam yatra rogavisheshah”

Vata dosha becomes enraged by frequent use of Kashaya(astringent), katu (pungent), Tikta (bitter), Alpahara(scanty diet), RukshaAhara(dry food articles), Abhojana(abstinence of food) or by regular riding on Ashva(horse), Ushtra(camel) or Yana(vehicle) etc;this agitated Vataenters into blood through carrying channels of the body and gets obstructed in its passage by vitiated Rakta Dhatu, thus affecting the entire blood and leading to Vatarakta.

Once again Acharya Charaka described that Vata due to its Sukshmatva (subtleness), Sarvasaratva (pervasiveness) properties and Rakta due to its Dravatva(liquidity), Saratva (flowing nature) properties; circulate through the body and blood vessels (RaktavahaSrotasa) and get obstructed in Sandhi(joints). Due to torsion nature of its course in joints;Rakta and Vata again get agitated. After localization and in combination with Pitta Dosha they cause different types of Shula (pain) according to predominance of Doshas. Vatarakta is an age old common condition prevalent all over the world.

On the basis of symptomatology and chronicity of disease, this can be correlated with a similar condition of modern medicine named as Gout.Gout is a clinical syndrome and is a group of metabolic diseases in which clinical manifestation is associated with tissue deposition of crystals of monosodium urate monohydrate from Hyperuricemia body fluids.

Incidence of Gout appears to have increased over in a few decades due to increasing industrialization,urbanization,faultydietary habits,radiation, drug toxicity and other factors responsible directly or indirectly for the disease Gout. Hyperuricemia and Gout may result from increased urate production or decreased uric acid excretion or both.

Reported prevalence of Gouty Arthritis is 2.0 to 2.6 per 1000 patients, usually between the age group of 25-50 years.

Sushruta explained Vatarakta entity in ‘Mahavatavyadhichikitsa’. Hence it is an identical one among all other vatavyadhyi. It is also known as vatashonita, khhuddavata, vatabalas, and aadhyavata.

Panchakarma is treatment modality used very extensively and effectively in Ayurveda. It plays an important role in Vatarakta. Acharya Charaka elaborate virechan as Shodhan karma in vaatrakta specifically in pittaj and raktaj type.

A medicine which is clinically viable, cost effective, easy to administer, gives early recovery and minimize the discomfort to the patient is in high demand. Kashmaryadi kashayas virechan kalpa is one of the preparations especially mentioned by charak. Acharya Charak has clearly mentioned the relevance of Kashmaryadi kashay as virechan kalpa in VataraktaChikitsa. So in the present study Kashmaryadi kashay as virechan has been selected.With this, NidanaParivarajana and PathyaApathya will be advised to the patients.Out of which I have selected Kashmaryadi kashay as virechan in one group and Ardhamatrik niruh basti in another group for given duration in Vataraktavya.

研究设计

研究类型
Interventional

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed patients of Vataraktawith symptom such asSandhishula,Sandhidaha, Sparshasahatva,Sandhishoth, Sandhivaivarnya.
  • Patient with raised Serum Uric Acid Level (more than 7.0 in Male and more than 6.0 in Female) Patients between age group 20 -70 years of either sex.
  • Patient willing for trial and giving written cosent.
  • Patient with all socio-economic status.
  • virechan arha and basti arha.

排除标准

  • Below 20yrs.
  • and above 70 years old patients With Known case of major systemic disorder such as IHD, MI, Uncontrolled DM, Uncontrolled Hypertension, CKD Patients other than Gouty Arthritis Virechan anarha and basti anarha Patient not willing for trial.
  • Pregnant and lactating mother.

结局指标

主要结局

decrease in serum uric acid level

时间窗: 7 days

次要结局

  • To compare the effect of Kashmaryadi kashay as virechan kalpa & ardhamatrik niruh basti as pain reliever in Vatarakta using VAS Scale.(To study the effect of Kashmaryadi kashay as virechan kalpa in decreasing Serum Uric Acid Level in Vatarakta using Serum Uric Acid test.)

研究者

发起方
Dr Shubhada Santosh Kulkarni
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验